Clinical Trial Update: D2 Versus D4 Corifollitropin Alfa in GnRH Antagonists [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating D2 versus D4 dosing of corifollitropin alfa in GnRH antagonist protocols has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Elonva (corifollitropin alfa)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Infertility | Phase 4 | Status: COMPLETED